F. Svedman

Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe – a systematic review of the literature

Johan Hansson, J. Hansson, D. Pillas, 2016, Clinical epidemiology.

Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma

Matteo Bottai, Johan Hansson, Hanna Eriksson, 2018, PloS one.

Response to ‘Surgical outcomes reflect the histological types of cutaneous malignant melanoma’

F. Svedman, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

LBA44 Lenvatinib (len) plus pembrolizumab (pembro) for advanced melanoma (MEL) that progressed on a PD-1 or PD-L1 inhibitor: Initial results of LEAP-004

A. Carneiro, G. Long, L. Ny, 2020 .

Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe – a systematic review of the literature

J. Hansson, D. Pillas, Aliki Taylor, 2016, Clinical epidemiology.

Lenvatinib (len) plus pembrolizumab (pembro) for patients (pts) with advanced melanoma and confirmed progression on a PD-1 or PD-L1 inhibitor: Updated findings of LEAP-004.

A. Carneiro, A. Arance, G. Long, 2021, Journal of Clinical Oncology.

Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience

V. Grozman, K. Holmsten, F. Svedman, 2024, Radiation oncology.

Surgical outcomes in patients with cutaneous malignant melanoma in Europe – a systematic literature review

J. Hansson, J. Amelio, A. Taylor, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.